Cargando…

Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms

OBJECTIVE: The objective of this study was to validate claims‐based algorithms for identifying acute giant cell arteritis (GCA) that will help generate real‐world evidence on comparative effectiveness research and epidemiologic studies. Among patients identified by the GCA algorithm, we further inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hemin, Tedeschi, Sara K., Chen, Sarah K., Monach, Paul A., Kim, Erin, Liu, Jun, Pethoe‐Schramm, Attila, Yau, Vincent, Kim, Seoyoung C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882520/
https://www.ncbi.nlm.nih.gov/pubmed/33491920
http://dx.doi.org/10.1002/acr2.11218
_version_ 1783651065510494208
author Lee, Hemin
Tedeschi, Sara K.
Chen, Sarah K.
Monach, Paul A.
Kim, Erin
Liu, Jun
Pethoe‐Schramm, Attila
Yau, Vincent
Kim, Seoyoung C.
author_facet Lee, Hemin
Tedeschi, Sara K.
Chen, Sarah K.
Monach, Paul A.
Kim, Erin
Liu, Jun
Pethoe‐Schramm, Attila
Yau, Vincent
Kim, Seoyoung C.
author_sort Lee, Hemin
collection PubMed
description OBJECTIVE: The objective of this study was to validate claims‐based algorithms for identifying acute giant cell arteritis (GCA) that will help generate real‐world evidence on comparative effectiveness research and epidemiologic studies. Among patients identified by the GCA algorithm, we further investigated whether GCA flares could be detected by using claims data. METHODS: We developed five claims‐based algorithms based on a combination of International Classification of Diseases, Ninth Revision (ICD‐9) diagnosis codes, specialist visits, and dispensed medications using Medicare Parts A, B, and D linked to electronic medical records (2006‐2014). Acute cases of GCA were determined by chart review using the treating physician’s diagnosis of GCA as the gold standard. Among the patients identified with acute GCA, we assessed if a GCA flare occurred during the year after initial diagnosis. RESULTS: The number of patients identified by each algorithm ranged from 220 to 896. Positive predictive values (PPVs) of the algorithms ranged from 60.7% to 84.8%. Requirement for disease‐specific workups, multiple diagnosis codes, or specialist visits improved the PPVs. The highest PPV (84.8%) was noted in an algorithm that required two or more diagnosis codes of GCA from inpatient, emergency department, or outpatient rheumatology visits plus a prednisone‐equivalent dose greater than or equal to 40 mg/day occurring 14 days before or after the second ICD‐9 diagnosis date, with the cumulative days’ supply greater than or equal to 14 days. Among patients identified as having GCA, 18.2% of patients had definite evidence of a flare and 25% had a potential flare. CONCLUSION: A claims‐based algorithm requiring two or more ICD‐9 diagnosis codes from inpatient, emergency department, or outpatient rheumatology visits and high‐dose glucocorticoid dispensing can be a useful tool to identify acute GCA cases in large administrative claims databases.
format Online
Article
Text
id pubmed-7882520
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78825202021-02-19 Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms Lee, Hemin Tedeschi, Sara K. Chen, Sarah K. Monach, Paul A. Kim, Erin Liu, Jun Pethoe‐Schramm, Attila Yau, Vincent Kim, Seoyoung C. ACR Open Rheumatol Original Articles OBJECTIVE: The objective of this study was to validate claims‐based algorithms for identifying acute giant cell arteritis (GCA) that will help generate real‐world evidence on comparative effectiveness research and epidemiologic studies. Among patients identified by the GCA algorithm, we further investigated whether GCA flares could be detected by using claims data. METHODS: We developed five claims‐based algorithms based on a combination of International Classification of Diseases, Ninth Revision (ICD‐9) diagnosis codes, specialist visits, and dispensed medications using Medicare Parts A, B, and D linked to electronic medical records (2006‐2014). Acute cases of GCA were determined by chart review using the treating physician’s diagnosis of GCA as the gold standard. Among the patients identified with acute GCA, we assessed if a GCA flare occurred during the year after initial diagnosis. RESULTS: The number of patients identified by each algorithm ranged from 220 to 896. Positive predictive values (PPVs) of the algorithms ranged from 60.7% to 84.8%. Requirement for disease‐specific workups, multiple diagnosis codes, or specialist visits improved the PPVs. The highest PPV (84.8%) was noted in an algorithm that required two or more diagnosis codes of GCA from inpatient, emergency department, or outpatient rheumatology visits plus a prednisone‐equivalent dose greater than or equal to 40 mg/day occurring 14 days before or after the second ICD‐9 diagnosis date, with the cumulative days’ supply greater than or equal to 14 days. Among patients identified as having GCA, 18.2% of patients had definite evidence of a flare and 25% had a potential flare. CONCLUSION: A claims‐based algorithm requiring two or more ICD‐9 diagnosis codes from inpatient, emergency department, or outpatient rheumatology visits and high‐dose glucocorticoid dispensing can be a useful tool to identify acute GCA cases in large administrative claims databases. John Wiley and Sons Inc. 2021-01-25 /pmc/articles/PMC7882520/ /pubmed/33491920 http://dx.doi.org/10.1002/acr2.11218 Text en © 2021 The Authors. ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Lee, Hemin
Tedeschi, Sara K.
Chen, Sarah K.
Monach, Paul A.
Kim, Erin
Liu, Jun
Pethoe‐Schramm, Attila
Yau, Vincent
Kim, Seoyoung C.
Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms
title Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms
title_full Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms
title_fullStr Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms
title_full_unstemmed Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms
title_short Identification of Acute Giant Cell Arteritis in Real‐World Data Using Administrative Claims‐Based Algorithms
title_sort identification of acute giant cell arteritis in real‐world data using administrative claims‐based algorithms
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882520/
https://www.ncbi.nlm.nih.gov/pubmed/33491920
http://dx.doi.org/10.1002/acr2.11218
work_keys_str_mv AT leehemin identificationofacutegiantcellarteritisinrealworlddatausingadministrativeclaimsbasedalgorithms
AT tedeschisarak identificationofacutegiantcellarteritisinrealworlddatausingadministrativeclaimsbasedalgorithms
AT chensarahk identificationofacutegiantcellarteritisinrealworlddatausingadministrativeclaimsbasedalgorithms
AT monachpaula identificationofacutegiantcellarteritisinrealworlddatausingadministrativeclaimsbasedalgorithms
AT kimerin identificationofacutegiantcellarteritisinrealworlddatausingadministrativeclaimsbasedalgorithms
AT liujun identificationofacutegiantcellarteritisinrealworlddatausingadministrativeclaimsbasedalgorithms
AT pethoeschrammattila identificationofacutegiantcellarteritisinrealworlddatausingadministrativeclaimsbasedalgorithms
AT yauvincent identificationofacutegiantcellarteritisinrealworlddatausingadministrativeclaimsbasedalgorithms
AT kimseoyoungc identificationofacutegiantcellarteritisinrealworlddatausingadministrativeclaimsbasedalgorithms